sesamin has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, FG; Deng, JL; Guo, ZH; Li, RQ; Li, X; Ma, YX; Pei, HT; Ren, JY; Sun, YT; Yin, BW; Zhang, F; Zhang, ZA; Zhu, SQ | 1 |
| Chang, CC; Cheng, HC; Chou, WC; Chu, PM; Hsieh, PL; Huang, YT; Lee, SD | 1 |
2 other study(ies) available for sesamin and Cardiovascular Diseases
| Article | Year |
|---|---|
Sesamin attenuates PM
Topics: Animals; Antioxidants; Cardiovascular Diseases; Dioxoles; Disease Models, Animal; Ferroptosis; Lignans; Particulate Matter; Rats; Rats, Sprague-Dawley | 2021 |
Sesamin suppresses angiotensin-II-enhanced oxidative stress and hypertrophic markers in H9c2 cells.
Topics: Angiotensin II; Cardiomegaly; Cardiovascular Diseases; Humans; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species | 2023 |